Streetbeat News

Products Services

AGLE

Aeglea BioTherapeutics has changed its name to Spyre Therapeutics and will trade under the symbol 'SYRE' starting November 28, 2023. The company appointed Cameron Turtle as CEO and added industry veterans Jeffrey Albers and Laurie Stelzer to its Board of Directors. Spyre is expanding its leadership team to develop therapeutic combinations for IBD, with lead programs SPY001 and SPY002 entering clinical studies in 2024. The company has a financial runway into 2026 with $205 million in cash and equivalents as of September 30, 2023.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:42 pm

IMAX

PATHE CINEMAS and IMAX Corporation have expanded their partnership with an agreement for five new IMAX with Laser systems in Europe, primarily France, and a three-picture slate agreement with PATHE LIVE for distribution across the IMAX network. The deal includes the release of a Filmed for IMAX ballet, 'Swan Lake', by Paris Opera and PATHE LIVE. IMAX continues to perform well in France, matching its highest grossing year at the French box office since 2019. The partnership between PATHE CINEMAS and IMAX dates back to 2010, with 26 locations across Europe and Morocco.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:41 pm

CYRX

Cryoport Inc. (NASDAQ:CYRX) and NIPPON EXPRESS HOLDINGS have formed a strategic partnership to provide global temperature-controlled supply chain services for the life sciences industry. The partnership combines Cryoport's integrated system, including shipping packages and bioservices, with Nippon Express' global logistics network. This collaboration aims to enhance Cryoport's logistics solutions and capabilities to support the life sciences and biopharmaceutical industries.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:40 pm

DRIO

DarioHealth Corp. (NASDAQ:DRIO) has secured a contract to provide its cardiometabolic solution to a national financial and business services company starting January 2024. The solution includes support for diabetes, pre-diabetes, weight management, hypertension, and GLP-1 medication users. Dario's approach combines technology and human support, aiming to improve clinical outcomes through sustained behavior change.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:38 pm

PGY

Pagaya Technologies LTD. (NASDAQ:PGY) has closed its fourth auto asset-backed securitization (ABS) deal of 2023, named RPM 2023-4, bringing its total auto issuance to $1.4 billion and overall ABS transactions to $6.3 billion for the year. The deal, rated by Kroll Bond Rating Agency, includes loans from a top 4 US auto captive and reflects Pagaya's growing network and investor demand. Pagaya's AI-driven financial products have attracted over $18 billion in ABS transactions since 2018, with a network of 90+ institutional investors.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:38 pm

BMY

PFE

PINC

Wall Street's most accurate analysts recommend holding three health care stocks with over 4% dividend yields: Pfizer Inc. (PFE), Bristol-Myers Squibb Company (BMY), and Premier, Inc. (PINC). Analysts from Morgan Stanley and Wells Fargo have maintained Equal-Weight ratings on PFE with reduced price targets. BMY saw a downgrade from BMO Capital to Market Perform and an upgrade from HSBC to Hold, with adjusted price targets. PINC maintained Neutral ratings from JP Morgan and UBS, with lowered price targets. Recent news includes FDA approvals for Pfizer's Xtandi and Bristol Myers Squibb's Augtyro, and Premier's upbeat earnings for Q1.

Portfolio Pulse from Lisa Levin

November 27, 2023 | 1:37 pm

GNE

Genie Energy Ltd.'s subsidiary, Sunlight Energy Investments, has acquired a portfolio of 12 operating solar arrays totaling 9.4 MW-DC from a project developer. These arrays, located in Ohio and Michigan, have long-term fixed-price PPAs with school facilities. The acquisition is expected to be immediately accretive to Genie Energy's bottom line. Sunlight Energy, which is primarily financed by Genie Energy, also obtained the right of first refusal on future projects from the developer.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:36 pm

ADBE

AFRM

PYPL

SPY

SQ

Adobe's 'Buy Now Pay Later' feature is projected to reach a record high in usage during Cyber Monday in the US, with an expected contribution of $782 million to online spending, marking an 18.8% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:35 pm

HTCR

HeartCore Enterprises, Inc.'s subsidiary Sigmaways has launched Psyche60s, a virtual reality experience aimed at combining entertainment with education. The project utilizes advanced technologies like Unity, Unreal Engine, Adobe Generative AI, Nvidia computing, and ChatGPT. HeartCore's CEO highlighted Sigmaways' role in the company's growth strategy and its potential for strategic partnerships in the education sector. Psyche60s is available on Oculus, SideQuest, Steam, Google Play, and the App Store.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:34 pm

INBS

Intelligent Bio Solutions Inc. (NASDAQ:INBS) has announced that State Road Constructions in Australia has chosen its Intelligent Fingerprinting Drug Screening System for workplace drug testing. This system, which uses fingertip sweat to detect drugs, offers a non-invasive and rapid solution for maintaining safety and compliance with health policies. The system is portable and aligns with State Road's focus on operational efficiency and respectful workplace practices.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:33 pm